Lunai Bioworks (LNAI) Preferred Shares (2023)

Lunai Bioworks (LNAI) posted quarterly Preferred Shares of $56.0 for Q4 2023, little changed quarter-over-quarter from $56.0 in Q3 2023.

Lunai Bioworks (LNAI) Preferred Shares (2023) Analysis & Trends

Lunai Bioworks' Preferred Shares history runs 1 years deep, the most recent figure standing at $56.0 for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.61 Bn	131.75 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.70 Bn	78.71 Bn	3.93 Bn	-
3	Argenx Se	65.28 Bn	60.09 Bn	1.37 Bn	-
4	Moderna	59.14 Bn	54.00 Bn	52.00 Mn	-
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.83 Bn	28.52 Bn	992.69 Mn	-
7	BioNTech SE	28.07 Bn	9.68 Bn	668.28 Mn	-
8	Insmed	27.54 Bn	26.38 Bn	358.27 Mn	-
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	-
10	Lunai Bioworks	7.03 Mn	3.87 Mn	20,942.00	-

Download Data

Date	Value
Dec 31, 2023	56.00
Sep 30, 2023	56.00